The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis. Evans JF, Ledwell OA, Tang Y, Rue R, et al. Am J Respir Cell Mol Biol 2025;72:643-652.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Evans JF, Ledwell OA, Tang Y, Rue R, et al. The Bi-steric Inhibitor RMC-5552 Reduces mTORC1 Signaling and Growth in Lymphangioleiomyomatosis. Am J Respir Cell Mol Biol 2025;72:643-652.
PMID: 39531634